Advertisement
Organisation › Details
WuXi AppTec Inc.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve the productivity of advancing healthcare products through cost-effective and efficient, socially responsible and sustainable solutions. With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec’s open-access platform is enabling more than 4,100 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that “every drug can be made and every disease can be treated.” *
Start | 2008-01-01 merged | |
Group | WuXi PharmaTech (Group) | |
Industry | pharma services | |
Industry 2 | contract manufacturing (biologicals) | |
Region | Shanghai | |
Country | China | |
City | n. a. Shanghai | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Quanterix Corporation. (2/12/21). "Press Release: Quanterix Announces Simoa Joint Laboratory with WuXi AppTec". Billerica, MA. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for WuXi PharmaTech (Group)
- [1] WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai....
- [2] Genezen, Inc.. (1/26/22). "Press Release: Genezen Appoints Senior Director of Business Development"....
- [3] Bristol-Myers Squibb Company. (8/3/21). "Press Release: Bristol Myers Squibb Completes Sale of Manufacturing Facility in Couvet, Switzerland". New York, NY....
- [4] Metrion Biosciences Ltd.. (7/26/21). "Press Release: Metrion Biosciences Appoints Nick Foster as Chief Commercial Officer and Head of Global Business Development". Cambridge....
- [5] WuXi AppTec. (7/20/21). Web Page: WuXi Global Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
- [6] WuXi AppTec. (7/20/21). Web Page: WuXi Healthcare Forum 2021. [https://www.wuxiapptec.com, 07/20/21]...
- [7] Oxford Genetics Ltd.. (3/2/21). "Press Release: WuXi AppTec Completes Acquisition of Oxgene to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers". Philadeliphia, PA & Oxford....
- [8] Almirall S.A.. (1/9/20). "Press Release: Almirall and WuXi Biologics Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases". Barcelona....
- [9] Genomics Medicine Ireland Ltd.. (8/12/19). "Press Release: Genomics Medicine Ireland Announces Strategic Advisory Board"....
- [10] Sphere Fluidics Ltd.. (2/18/19). "Press Release: Oxford Genetics and Sphere Fluidics Announce a Multi-partner Collaboration to Expedite the Development of Automated Microfluidic Systems for Rapid and High-throughput Gene Editing in Mammalian Cell Lines"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top